Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Tamsulosin may slightly increase dementia risk compared to other treatments for enlarged prostate.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Serenoa repens is a common and effective plant-based treatment for mild-to-moderate prostate enlargement symptoms.

The new finasteride delivery system using chitosan-based nanoniosomes shows promise for prostate cancer prevention.

Metabolic syndrome worsens treatment outcomes for urinary symptoms in men with enlarged prostate.

Arachis hypogaea L. root extract reduces prostate enlargement and inflammation in mice.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Serenoa repens is not proven effective for hair loss and may delay prostate cancer detection.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

TURP specimens should be checked for various tumors, not just common prostate issues.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.